![]() |
市場調查報告書
商品編碼
1380422
2023-2030 年全球醫療保健市場電腦視覺Global Computer Vision in Healthcare Market 2023-2030 |
預計在預測期內(2023-2030 年),醫療保健市場的全球電腦視覺將以 43.2% 的CAGR成長。電腦視覺在醫療保健領域有廣泛的應用,例如診斷影像、病理學、外科手術、病患監護、藥物發現和遠距醫療等。電腦視覺的使用減少了出錯的機會,提高了疾病診斷、手術干涉和遠端患者評估的速度和準確性,最終改善了醫療保健結果。除此之外,對具有成本效益的解決方案不斷成長的需求以及醫療錯誤的減少都推動了其採用。這些組合要素在加強病患照護和簡化醫療保健系統效率方面發揮著至關重要的作用。
全球醫療保健市場電腦視覺根據類型、應用程式和最終用戶進行細分。根據類型,市場分為軟體、硬體和服務。根據應用,市場細分為醫學影像和診斷、手術、患者監護以及藥物發現、患者教育和康復等其他應用。根據最終用戶,市場細分為醫療保健提供者、診斷中心、學術研究機構以及製藥公司和醫療器材公司等其他機構。在最終用戶中,製藥業對基於電腦視覺的解決方案的需求正在不斷成長。在藥品製造中,電腦視覺可用於多種應用,例如產品品質檢查、包裝檢測、壓印藥品標籤分類和清潔檢查。獲得嚴格的 FDA 法規來維持和提高產品品質、製藥行業的持續成長以及監管機構對將 AI/ML 等新技術涵蓋製造過程的日益支持,正在推動製藥行業對電腦視覺技術的需求。例如,根據美國 FDA 的器械品質系統規定,製造商必須建立並遵循品質體系,以協助確保其產品始終符合適用的要求和規範。考慮到不斷成長的需求和用例,科技公司也將重點放在與製藥業相關的產品上。
其中,醫療器材細分市場預計將佔據顯著的市場佔有率。基於電腦視覺的醫療設備在醫療保健領域有著廣泛的應用,可顯著提高病患照護和診斷準確性。它們用於診斷成像、病理分析和手術精度,確保更好、更精確的醫療評估和治療。除此之外,這些設備還用於遠距患者監護、遠距醫療諮詢、牙科影像和眼科評估,所有這些都共同提高了醫療保健服務的效率和有效性。
醫療保健市場的全球電腦視覺根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於醫療保健的可及性更好以及終端用戶行業市場領導者的大量存在等因素,北美在市場中佔有相當大的佔有率。此外,對人工智慧/機器學習等先進技術的投資不斷增加,技術進步也不斷增加。例如,2023 年 2 月,Modular Devices 和 O2 Investment Partners 的投資組合公司向 Interim Diagnostic Imaging 投資了一筆金額未揭露的資金。透過此次合作,該公司將專注於研發和產品組合擴展。
根據國際貨幣基金組織的數據,亞太地區擁有全球 60% 的人口。由於人口占全球人口的大多數且正在顯著成長,地方政府正致力於透過引入更好的政策、投資和採用人工智慧/機器學習等先進技術來改善醫療保健系統,以提高醫療保健效率。此外,主要區域經濟體也紛紛推出政策來促進醫療器材、醫院等終端用戶產業的發展。例如,2022 年 7 月,印度政府提出了新的《2022 年藥品、醫療器材和化妝品法案》草案,以確保並提供徹底的法律保護,以確保在印度銷售的醫療用品可靠、高效、符合要求。要求的標準。這些措施也幫助 SigTuple 和 Qure.ai 等區域公司在國際市場上保持競爭力。
服務全球醫療保健電腦視覺的主要公司包括: Enlitic, Inc.、Caption Health, Inc.、推想醫療科技有限公司和 Medtronic, plc 等。市場參與者透過各種策略(包括併購、合作夥伴關係和融資)來維持市場競爭力,為市場成長做出了巨大貢獻。例如,2022 年 1 月,DarioHealth Corp. 收購了 Physimax Technologies Ltd。Physimax Technologies 是一家用於肌肉骨骼 (MSK) 功能篩檢和損傷預測風險評估的電腦視覺技術提供者。該技術目前已被多個組織投入商業使用,包括 NBA 和 NFL 球隊、美國軍方以及專門從事骨科護理的醫療機構。
Title: Global Computer Vision in Healthcare Market Size, Share & Trends Analysis Report by Type (Hardware, Software, and Services), by Application (Medical Imaging & Diagnostics, Surgeries, Patient Monitoring, and Others), and by End User (Healthcare Providers, Diagnostic Centers, Academic Research Institutes, and Others)Forecast Period (2023-2030).
The global computer vision in the healthcare market is anticipated to grow at a CAGR of 43.2% during the Forecast Period (2023-2030). Computer vision has a wide range of applications in healthcare such as diagnostic imaging, pathology, surgical procedures, patient monitoring, drug discovery, and telemedicine, among others. Usage of computer vision reduces the chances of errors and improves speed, and accuracy of disease diagnosis, surgical interventions, and remote patient assessments, ultimately leading to enhanced healthcare outcomes. Apart from this, the growing demand for cost-effective solutions, and decreased medical errors, are all driving its adoption. These combined elements play a crucial role in enhancing patient care and streamlining the efficiency of the healthcare system.
The global computer vision in healthcare market is segmented based on the type, application, and end user. Based on type, the market is sub-segmented into software, hardware, and services. Based on application, the market is sub-segmented into medical imaging & and diagnostics, surgeries, patient monitoring, and other applications such as drug discovery, patient education, and rehabilitation. Based on end users, the market is sub-segmented into healthcare providers, diagnostic centers, academic research institutes, and others such as pharmaceutical companies, and medical device companies. Among the end users, significant demand for computer vision-based solutions is growing in the pharmaceutical industry. In pharmaceutical manufacturing, computer vision can be used for multiple applications such as quality inspection of a product, packaging detection, classification of imprinted pharmaceutical labels, and cleaning inspections. Getting stringent FDA regulations to maintain and improve product quality, the continuous growth of the pharmaceutical industry, and growing support from regulators for the inclusion of new technologies such as AI/ML in the manufacturing processes are driving demand for computer vision technology in the pharmaceutical industry. For instance, according to the USFDA quality system regulation for devices, Manufacturers must establish and follow quality systems to help ensure that their products consistently meet applicable requirements and specifications. Considering growing demand and use cases, technology companies are also focusing on products related to the pharmaceutical industry.
Among the types, the medical devices sub-segment is anticipated to hold a prominent share of the market. Computer vision-based medical devices have a wide range of applications across healthcare, significantly enhancing patient care and diagnostic accuracy. They are used in diagnostic imaging, pathology analysis, and surgical precision, ensuring better and more precise medical assessments & and treatments. Apart from this, these devices are used for remote patient monitoring, telemedicine consultations, dental imaging, and ophthalmology assessments, all of which collectively contribute to the efficiency and effectiveness of healthcare services.
The global computer vision in the healthcare market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America holds a considerable share in the market due to factors such as better accessibility of healthcare, and the significant presence of market leaders in end-user industries. Furthermore, the growing investments in advanced technologies such as AI/ML, and technological advancements. For instance, in February 2023 Modular Devices and the portfolio company of O2 Investment Partners invested an undisclosed amount in Interim Diagnostic Imaging. With this partnership, the company will focus on research and development, and product portfolio expansion.
Asia-Pacific region holds 60% of the global population, according to the International Monetary Fund. With a majority share of the global population, which is growing significantly, the regional governments are focusing on improving healthcare systems by introducing better policies, investments, and the inclusion of advanced technologies such as AI/ML to improve healthcare efficiency. Additionally, the major regional economies are also introducing policies to promote end-user industries such as medical devices, and hospitals industry. For instance, In July 2022, the government of India tabled a draft for the new Drugs, Medical Devices and Cosmetics Bill 2022, to assure and offer thorough legal protections to ensure that the medical items sold in India are reliable, efficient, and up to required standards. These initiatives are also helping regional companies such as SigTuple, and Qure.ai to stay competitive in the international market.
The major companies serving the global computer vision in healthcare include: Enlitic, Inc., Caption Health, Inc., Infervision Medical Technology Co., Ltd., and Medtronic, plc among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, and funding to stay competitive in the market. For instance, in January 2022, DarioHealth Corp. acquired Physimax Technologies Ltd. Physimax Technologies is a provider of computer vision technology utilized for Musculoskeletal (MSK) functional screening and predictive risk assessment of injuries. This technology is currently in commercial use by various organizations, including NBA and NFL teams, the US military, and healthcare facilities specializing in orthopedic care.